Ace the West Virginia MPJE 2026 – Pharmacist Pro Power-Up!

Narcotic Treatment Programs, which provide treatment for individuals with opioid use disorders, require a specific DEA registration form for proper compliance with federal regulations. The correct form needed for these programs is DEA Form 363. This form is specifically designed for the registration of entities that wish to dispense narcotics for the treatment of opioid addiction.

DEA Form 363 encompasses the requirements for narcotic treatment facilities, including provisions for the use of methadone and other narcotics in a treatment setting. By utilizing this form, facilities affirm their commitment to adhere to the necessary federal regulations that govern the treatment of substance use disorders.

In contrast, DEA Form 106 is used to report theft or loss of controlled substances, DEA Form 222 facilitates the ordering of Schedule I and II controlled substances, and DEA Form 224 is utilized for the registration of a practitioner or a pharmacy to dispense controlled substances. Each of these forms serves distinct purposes unrelated to the operation of Narcotic Treatment Programs. This differentiation emphasizes the importance of understanding the specific role and requirements of each registration form within the context of pharmacy practice and drug regulation.